Key Takeaways for Altria Group Stock as of August 2026
- Round-Trip Year: Altria stock closed at $65.08 on August 13, down just 0.6% over the past year even after sliding to $57.66 in late December and rallying past $75 by early July.
- Ratings Split: The Street carries 4 buys, 8 holds, 1 underperform and 1 sell on Altria stock, with a $70.00 mean target sitting ~8% above the current price.
- Model Upside: TIKR’s mid-case model targets $90.65 for Altria stock by late 2030, implying 39.3% total return and 7.8% annualized.
- Q2 Miss: Shares fell 9.1% on Jul 30 after adjusted EPS of $1.48 missed the $1.50 estimate.
Why Altria Stock’s Round Trip From $55 to $75 Ended Right Back Where It Started
Altria Group (MO) stock closed at $65.08 on August 13, almost exactly where it traded a year earlier, a 0.6% return that makes the stock look dormant. It was not. Shares slid to a $57.66 close on December 31, rallied more than 30% to trade above $75 by late June and early July, then fell 9.1% in a single session on July 30 after a second-quarter earnings miss.
The December low tracked a broader concern the company itself flagged all year: a squeezed consumer trading down out of premium cigarettes. CEO Salvatore Mancuso addressed that pressure directly on the Q2 earnings call: “The consumer remains under pressure. Gas prices and inflation remain elevated, driven primarily by the uncertainty and the geopolitical climate that they are living in today.” That dynamic, not a company-specific stumble, set the floor the stock bounced off in January.
The rebound that followed had a real catalyst. In late May, the FDA laid out an “enforcement discretion” policy letting some nicotine pouch and vape products reach the market without full authorization, a shift analysts called constructive for Altria’s on! and NJOY portfolios and one that helped carry the stock from the high $50s toward $75 through June.
Then the Q2 report landed. Adjusted earnings per share of $1.48 missed the $1.50 consensus, Marlboro shipment volumes fell 7.4% and On! nicotine pouch shipments dropped 4.2% as competitors expanded their own pouch lineups. The stock dropped from $74.92 to roughly $68 that day and kept sliding to $65.08 by August 13. The net effect: a five-month rally erased in two weeks, leaving Altria stock’s one-year chart flat not because nothing happened, but because two nearly equal moves canceled each other out.
Altria Stock’s Target Climbed All Year Even as the Price Went Nowhere
The Street’s current view on Altria stock splits into 4 buys, 8 holds, 1 underperform and 1 sell, with a $70.00 mean target that sits roughly 8% above the August 13 close. Coverage has narrowed slightly, from 13 analysts publishing targets in June 2025 to 11 today.
What stands out is the direction of the target itself. The mean climbed from $58.28 in June 2025 to $62.88 by September, dipped only modestly to $62.42 during the December selloff, then kept rising through the first half of 2026 to $70.36 by June 30, roughly tracking the stock’s own climb toward $75.
The Q2 miss barely dented that consensus: the mean target eased just 36 cents to $70.00, even as individual firms moved in both directions, Barclays cutting its target to $58 from $64 while others held closer to the group average. Analysts, in other words, treated the earnings miss as a demand-timing issue rather than a reason to abandon the thesis that carried the target higher all year.
TIKR Values Altria Stock at $91, Pricing In a Slow Multiple Recovery
TIKR’s mid-case model values Altria stock at $90.65 by late 2030, implying a 39.3% total return from the current $65.08 price, or 7.8% annualized over 4.4 years.
That annualized rate positions Altria stock as a steady, dividend-anchored compounder rather than a re-rating story, closer to what investors expect from a mature tobacco name than a growth name chasing multiple expansion.
The gap between the model’s target and the Street’s $70 consensus reflects timeline more than disagreement: both sides expect Altria to work through the same premium-volume pressure Mancuso described on the call, but TIKR’s model extends the recovery further out, past the on! PLUS and NJOY ACE launches management flagged for later this year, to capture the full swing back toward Marlboro’s historic pricing power.
TIKR’s model puts Altria’s target at $91 Pull up the full valuation breakdown on TIKR for free →
Should You Invest in Altria Group, Inc.?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Altria Group, Inc. stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Altria Group, Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze MO stock on TIKR for Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
